Solid beverage capable of improving dysmenorrhea in women

Abstract

The invention discloses a solid beverage capable of improving dysmenorrhea in women. The solid beverage capable of improving dysmenorrhea in women is prepared from the following raw materials according to a certain weight ratio: fruits of plukenetia volubilislinneo, kudzuvine roots, linseeds, chia seeds, a haematococcus pluvialis extract, a rosemary extract, soybean isoflavones, probiotics, prebiotics, citric acid, brown sugar, and vitamins. The adopted raw materials interact so as to improve dysmenorrhea conditions from multiple aspects, as well as relieve uterine smooth muscle sensitivity caused by estrogen; and magnesium ion concentration in the uterine muscle cells is increased so as to decrease stimulation of external active substances on the uterine muscle cells, and thus, uterine smooth muscle tension is reduced so that the purpose of treating dysmenorrhea is achieved; moreover, production of prostaglandin PGF2-alpha, prostaglandin LT4 and free radicals which cause dysmenorrheaof the body is reduced, contracture of uterine smooth muscle is relived by reducing occurrence of ischemia-reperfusion injuries in the uterus, and intestinal flora are improved so as to raise absorption and utilization rates of active ingredients so that survival and growth of probiotics in the body are facilitated.

Description

technical field [0001] The invention relates to a solid beverage with medical and health care functions, in particular to a solid beverage capable of improving women's dysmenorrhea, and belongs to the field of health food. Background technique [0002] Dysmenorrhea refers to the condition that women experience abdominal cramping pain, lower abdominal pain, headache, fatigue, dizziness, nausea, vomiting, diarrhea, abdominal distension, low back and leg pain before and after menstruation or during menstruation, which affect life and work. Most women's dysmenorrhea is primary dysmenorrhea, and there are many reasons for primary dysmenorrhea, such as uneven secretion of estrogen, excessive synthesis and release of prostaglandins or leukotrienes, increased secretion of vasopressin and oxytocin, etc. Existing treatment methods are mainly drug therapy and food therapy. Drug therapy such as non-steroidal anti-inflammatory drugs (NSAIDs), cyclooxygenase 2 (COX-2) inhibitors, oral sh...

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to address the increasingly prominent problem of women's dysmenorrhea, overcome the defects of single medicine, large side effects and poor effect, and disclose a solid beverage that can improve women's dysmenorrhea